| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |